Patents by Inventor Vivien Chavanelle

Vivien Chavanelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11191744
    Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: December 7, 2021
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Vivien Chavanelle, Florian Le Joubioux, Pascal Sirvent, Thierry Maugard
  • Publication number: 20200368303
    Abstract: A composition comprising at least a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum. This composition is in particular useful as a nutritional product or health product to prevent and/or combat fat and/or carbohydrate metabolism disorders in Humans or animals.
    Type: Application
    Filed: August 11, 2020
    Publication date: November 26, 2020
    Inventors: Sebastien Peltier, Vivien Chavanelle, Pascal Sirvent
  • Patent number: 10813965
    Abstract: A composition comprising at least a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum. This composition is in particular useful as a nutritional product or health product to prevent and/or combat fat and/or carbohydrate metabolism disorders in Humans or animals.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: October 27, 2020
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE
    Inventors: Sebastien Peltier, Vivien Chavanelle, Pascal Sirvent
  • Publication number: 20200009101
    Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H -pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.
    Type: Application
    Filed: February 13, 2018
    Publication date: January 9, 2020
    Inventors: Sebastien PELTIER, Vivien CHAVANELLE, Florian LE JOUBIOUX, Pascal SIRVENT, Thierry MAUGARD
  • Publication number: 20180311294
    Abstract: A composition comprising at least a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum. This composition is in particular useful as a nutritional product or health product to prevent and/or combat fat and/or carbohydrate metabolism disorders in Humans or animals.
    Type: Application
    Filed: October 20, 2016
    Publication date: November 1, 2018
    Inventors: Sebastien Peltier, Vivien Chavanelle, Pascal Sirvent